BIB ETF is best suited for high-risk, active investors in the accumulation phase or retirees managing portfolios hands-on.

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund ...

The investment seeks daily investment results, before fees and expenses, of 200% of the daily performance of the NYSE Biotechnology Index. The fund, under normal circumstances, invests at least 80% of ...

A smart beta exchange traded fund, the iShares Biotechnology ETF (IBB) debuted on 02/05/2001, and offers broad exposure to the Health Care ETFs category of the market. What Are Smart Beta ETFs? Market ...

The iShares Biotechnology ETF (IBB) provides exposure to healthcare innovation with a focus on the biggest firms by market ...

The VanEck Biotech ETF (BBH) provides market-cap-weighted exposure to leading U.S.-listed biotechnology firms.

Biotech ETFs have had a banner year, earning some investors returns north of 30 percent since January. I say “some investors” because, it turns out, not all biotech ETFs are created equal. In our 2012 ...

You should consider the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on February 5, 2001. Retail and institutional investors increasingly turn to passively ...

Launched on 02/05/2001, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.